Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Oct 31, 2014

Filed with the SEC on Dec 15, 2014 and accepted by EDGAR at Dec 15, 2014, 08:33 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-10-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2014-08-01 to 2014-10-31$1.2mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2014-05-01 to 2014-10-31$2.7mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-08-01 to 2014-10-31−$3.7mus-gaap:OperatingIncomeLoss
Operating income6 months2014-05-01 to 2014-10-31−$7.4mus-gaap:OperatingIncomeLoss
Income tax3 months2014-08-01 to 2014-10-31$10.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2014-05-01 to 2014-10-31$15.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-08-01 to 2014-10-31−$3.1mus-gaap:NetIncomeLoss
Net income6 months2014-05-01 to 2014-10-31−$6.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-08-01 to 2014-10-31−$0.05us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2014-05-01 to 2014-10-31−$0.11us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-08-01 to 2014-10-31−$0.05us-gaap:EarningsPerShareBasic
Basic EPS6 months2014-05-01 to 2014-10-31−$0.10us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-08-01 to 2014-10-3167,855,325 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2014-05-01 to 2014-10-3167,854,228 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2014-05-01 to 2014-10-31−$5.2mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure6 months2014-05-01 to 2014-10-31$71.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-10-31$575.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-10-31$2.1mus-gaap:AssetsCurrent
Total assetsAt period end2014-10-31$3.3mus-gaap:Assets
Current liabilitiesAt period end2014-10-31$3.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-10-31$5.2mus-gaap:Liabilities
Shareholders' equityAt period end2014-10-31−$1.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-14-073848. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.